Your browser doesn't support javascript.
loading
Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.
Dai, Yongdong; Liu, Lulu; Zeng, Tingting; Liang, Jian-Zhong; Song, Ye; Chen, Kai; Li, Yan; Chen, Leilei; Zhu, Ying-Hui; Li, Jiangchao; Li, Yan; Xie, Dan; Yuan, Yun-Fei; Guan, Xin-Yuan.
Afiliação
  • Dai Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China; Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang Univ
  • Liu L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China; Cancer Biotherapy Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Republic of China.
  • Zeng T; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Liang JZ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Song Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Chen K; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Li Y; Department of Biology, Southern University of Science and Technology, Shenzhen, Republic of China.
  • Chen L; Department of Clinical Oncology, the University of Hong Kong, Hong Kong, Republic of China.
  • Zhu YH; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Li J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Li Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Xie D; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Yuan YF; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China.
  • Guan XY; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Republic of China; Department of Clinical Oncology, the University of Hong Kong, Hong Kong, Republic of China. Electronic address: xyguan@hku.hk.
Am J Pathol ; 188(2): 378-391, 2018 02.
Article em En | MEDLINE | ID: mdl-29174628

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Via de Sinalização Wnt / Neoplasias Hepáticas / Mucinas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Via de Sinalização Wnt / Neoplasias Hepáticas / Mucinas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article